Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eur J Obstet Gynecol Reprod Biol ; 288: 108-113, 2023 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-37499277

RESUMO

Pelvic floor dysfunction (PFD) is a common complication in gynecologic cancer survivors (GCS) and is now a worldwide medical and public health problem because of its great impact on the quality of life of GCS. PFD after comprehensive gynecologic cancer treatment is mainly reflected in bladder function, rectal function, sexual dysfunction and pelvic organ prolapse (POP), of which different types of gynecologic cancer correspond to different disease incidence. The prevention strategies of PFD after comprehensive gynecologic cancer treatment mainly included surgical treatment, physical therapy and behavioral guidance, etc. At present, most of them still focus on physical therapy, mostly using Pelvic Floor Muscle Training (PFMT) and multi-modal PFMT treatment of biofeedback combined with electrical stimulation, which can reduce the possibility of PFD after surgery in GCS to some extent. This article reviews the clinical manifestations, causes and current research progress of prevention and treatment methods of PFD after comprehensive treatment for GCS.


Assuntos
Sobreviventes de Câncer , Neoplasias , Distúrbios do Assoalho Pélvico , Prolapso de Órgão Pélvico , Incontinência Urinária , Feminino , Humanos , Incontinência Urinária/etiologia , Incontinência Urinária/terapia , Incontinência Urinária/epidemiologia , Diafragma da Pelve , Qualidade de Vida , Distúrbios do Assoalho Pélvico/etiologia , Distúrbios do Assoalho Pélvico/terapia , Distúrbios do Assoalho Pélvico/epidemiologia , Prolapso de Órgão Pélvico/cirurgia , Prolapso de Órgão Pélvico/complicações , Terapia por Exercício
2.
Int J Dev Neurosci ; 83(5): 466-478, 2023 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-37309082

RESUMO

BACKGROUND: Postpartum depression (PPD) is a prevalent psychiatric disorder during the postnatal period, and it exerts adverse impacts not only on mothers but also on infants, impairing the well-being of the whole family. However, the role of peptides in the breast milk of mothers with PPD has not been studied. The purpose of this study was to unveil the peptidomic profile of PPD from breast milk samples. METHODS: We performed comparative peptidomic profiling of human breast milk from PPD and control mothers using liquid chromatography-tandem mass spectrometry technology with iTRAQ-8 labelling. GO and KEGG pathway analyses of precursor proteins were used to predict the underlying biological functions of differentially expressed peptides (DEPs). Ingenuity Pathway Analysis (IPA) was further performed to explore the interactions and involved pathways of DEPs. RESULTS: A total of 294 peptides from 62 precursor proteins were identified to be differentially expressed in the breast milk of PPD mothers compared with the control group. Bioinformatics analysis predicted that these DEPs were associated with ECM-receptor interaction, neuroactive ligand-receptor interaction, cell adhesion molecule binding and oxidative stress in macrophages. These results indicate that DEPs from human breast milk may play a part in PPD and become promising noninvasive biomarkers.


Assuntos
Depressão Pós-Parto , Lactente , Feminino , Humanos , Leite Humano/química , Mães/psicologia , Biomarcadores/metabolismo , Peptídeos/análise , Peptídeos/metabolismo
3.
J Ovarian Res ; 16(1): 5, 2023 Jan 07.
Artigo em Inglês | MEDLINE | ID: mdl-36611197

RESUMO

BACKGROUND: Ovarian cancer (OC) is the most fatal gynaecological malignancy and has a poor prognosis. Glycosylation, the biosynthetic process that depends on specific glycosyltransferases (GTs), has recently attracted increasing importance due to the vital role it plays in cancer. In this study, we aimed to determine whether OC patients could be stratified by glycosyltransferase gene profiles to better predict the prognosis and efficiency of immune checkpoint blockade therapies (ICBs). METHODS: We retrieved transcriptome data across 420 OC and 88 normal tissue samples using The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) databases, respectively. An external validation dataset containing 185 OC samples was downloaded from the Gene Expression Omnibus (GEO) database. Knockdown and pathway prediction of B4GALT5 were conducted to investigate the function and mechanism of B4GALT5 in OC proliferation, migration and invasion. RESULTS: A total of 50 differentially expressed GT genes were identified between OC and normal ovarian tissues. Two clusters were stratified by operating consensus clustering, but no significant prognostic value was observed. By applying the least absolute shrinkage and selection operator (LASSO) Cox regression method, a 6-gene signature was built that classified OC patients in the TCGA cohort into a low- or high-risk group. Patients with high scores had a worse prognosis than those with low scores. This risk signature was further validated in an external GEO dataset. Furthermore, the risk score was an independent risk predictor, and a nomogram was created to improve the accuracy of prognostic classification. Notably, the low-risk OC patients exhibited a higher degree of antitumor immune cell infiltration and a superior response to ICBs. B4GALT5, one of six hub genes, was identified as a regulator of proliferation, migration and invasion in OC. CONCLUSION: Taken together, we established a reliable GT-gene-based signature to predict prognosis, immune status and identify OC patients who would benefit from ICBs. GT genes might be a promising biomarker for OC progression and a potential therapeutic target for OC.


Assuntos
Neoplasias dos Genitais Femininos , Neoplasias Ovarianas , Feminino , Humanos , Imunoterapia , Neoplasias Ovarianas/genética , Neoplasias Ovarianas/terapia , Prognóstico , Glicosiltransferases/metabolismo
4.
Nanotechnology ; 31(9): 095401, 2020 Feb 21.
Artigo em Inglês | MEDLINE | ID: mdl-31711047

RESUMO

Despite many recent attempts to restrict it, the dissolution and diffusion of polysulfides, leading to inferior cycling performance, is still the main bottleneck hindering commercialization of the Li-S battery. Herein, a new strategy of using lithium polyacrylate (LiPAA) to clad multiwalled carbon nanotube/sulfur (MWNT/S) composites as the interface layer for an MWNT/S/LiPAA cathode was proposed, not only to suppress polysulfide migration through physical encapsulation and chemical adsorption, but also to facilitate Li+ diffusion during the charge/discharge process. Attributed to these functions of LiPAA, MWNT/S/LiPAA exhibited a rate capability and cycling performance superior to those of MWNT/S and MWNT/S/PAA. Moreover, thanks to the introduction of LiPAA, the MWNT/S/LiPAA was endowed with robust mechanical properties, making it suitable for a flexible cathode in a flexible Li-S battery with stable output under deformation. This work could open up a promising way to suppress polysulfide migration for high-performance flexible Li-S batteries.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...